Table 5.
Group | Heart | Liver | Kidney | WAT visceral | WAT subcutaneous | Brain |
---|---|---|---|---|---|---|
Control (n = 8) | 20.1 ± 1.9 | 10.5 ± 0.5 | 21.7 ± 0.9 | 9.5 ± 0.6 | 6.7 ± 0.8 | 75.3 ± 10.0a |
Propylthiouracil (n = 4) | 51.4 ± 17.5 | 66.3 ± 17.5* | 27.6 ± 4.9 | 87.5 ± 7.6** | 59.1 ± 17.4** | 331.0 ± 97.1**, a |
T3 treatment (n = 5) | 122.6 ± 49.2** | 74.0 ± 34.6* | 156.4 ± 51.4** | 72.4 ± 17.9** | 42.1 ± 11.4** | 421.1 ± 59.6**, b |
T4 treatment (n = 3) | 8.7 ± 0.6 | 10.1 ± 4.4 | 15.5 ± 2.2 | 6.0 ± 1.1 | 4.3 ± 1.1 | 20.5 ± 1.7c |
Results are expressed as percentages and represent means ± SEM. WAT = White adipose tissue. Two-way ANOVA yielded p < 0.001 for the effect of treatment and p < 0.001 for the effect of tissue. Comparisons between specific groups performed within rows and within columns yielded the results summarized by the following symbols:
p < 0.05 versus control;
p < 0.01 versus control by Dunnet's post hoc test;
p < 0.01 versus any other tissue;
p < 0.05 versus liver and p < 0.01 versus any other tissue;
p < 0.05 versus heart and p < 0.01 versus WAT by Tukey's post hoc test.